Skip to main content
. 1998 Dec 15;18(24):10257–10268. doi: 10.1523/JNEUROSCI.18-24-10257.1998

Table 3.

Inhibition by cocaine of m-tyramine-induced DA efflux as a function of DA concentrations

Initial [DA]om) [DA]o at steady state (nm) [DA]i at steady state (μm) IC50m)3-a Kim)3-a
n = 12 n = 4 n = 3 n = 3
0.5 23  ± 4 44 11.6  ± 0.6 2.05  ± 0.07
1.0 27  ± 5 84 12.2  ± 0.6 2.23  ± 0.16
1.5 44  ± 3 124 12.9  ± 1.3 2.17  ± 0.04
2.0 88  ± 8 163 12.4  ± 0.8 2.15  ± 0.11
3.0 184  ± 15 242 11.0  ± 1.2 2.22  ± 0.12
4.0 359  ± 38 321 13.4  ± 1.5 2.47  ± 0.24

m-Tyramine (10 μm) and cocaine (0–30 μm) were added at the same time. The data at 0.5, 1, 2, 3, and 4 μm initial [DA]o were obtained from the same experiments as in Fig. 5. The data at 1.5 μm initial [DA]o were obtained from other experiments. IC50 was computed by nonlinear fitting the efflux data with logistic equation. All Hill numbers were close to unity (data not shown). For Ki, data were analyzed by the least square linear regression of the v/v′ as a function of the concentrations of an inhibitor.Ki was estimated according to the equation:Ki = 1/{slope of the regression linex (1 + [S]/Ks)}. [S] is the m-tyramine concentration.Ks is the Michaelis–Menten constant form-tyramine to induce DA efflux, and was set at 2.02 μm, which was the average value determined in separate saturation curves (see Table 4). [DA]o at steady state was measured by RDE voltammetry. [DA]i was estimated from the linear regression equation expressing the relationship between initial [DA]o and [DA]i (see Fig. 1). The values are means ± SE of n experiments.

F3-a

No significant difference for any [DA] (Newman–Keuls test).